Missing The Point (Of Care): FDA Misreading Of CLIA Waiver Law Undermines Cost-Effective Health Testing

By James A. Boiani, a senior associate in the Washington, D.C. office of the law firm Epstein Becker & Green P.C., and Stuart M. Gerson, a partner with Epstein Becker & Green P.C.